CymaBay Therapeutics Inc (CBAY) stock is up 45.01% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CBAY stock a score of 83 out of a possible 100.
That rank is influenced by a long-term technical score of 97. CBAY's rank also includes a short-term technical score of 80. The fundamental score for CBAY is 72. In addition to the average rating from Wall Street analysts, CBAY stock has a mean target price of 12.06. This means analysts expect the stock to add 62.75% over the next 12 months.
What's Happening with CBAY Stock Today
CymaBay Therapeutics Inc (CBAY) stock has risen 2.32% while the S&P 500 is up 0.14% as of 10:42 AM on Thursday, Oct 1. CBAY is up $0.17 from the previous closing price of $7.24 on volume of 1,197,179 shares. Over the past year the S&P 500 has risen 16.63% while CBAY is up 45.01%. CBAY lost -$1.16 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on CymaBay Therapeutics Inc (CBAY) Stock.